Literature DB >> 12643485

The effects of ractopamine on the behavior and physiology of finishing pigs.

J N Marchant-Forde1, D C Lay, E A Pajor, B T Richert, A P Schinckel.   

Abstract

The objectives of this study were to examine the effects of ractopamine (RAC) on the behavior and physiology of pigs during handling and transport. Twenty-four groups of three gilts were randomly assigned to one of two treatments 4 wk before slaughter: finishing feed plus RAC (10 ppm) or finishing feed alone. Pigs were housed in the same building in adjacent pens with fully slatted floors and ad libitum access to feed and water. Behavioral time budgets were determined in six pens per treatment over a single 24-h period during each week. Behavioral responses of these pigs to routine handling and weighing were determined at the start of the trial and at the end of each week. Heart-rate responses to unfamiliar human presence were measured in all pigs and blood samples were taken from a single pig in each pen on different days during wk 4. At the end of wk 4, all pigs were transported for 22 min to processing. Heart rate was recorded from at least one pig per pen during transport and a postmortem blood sample was taken from those pigs that were previously sampled. During wk 1 and 2, RAC pigs spent more time active (P < 0.05), more time alert (P < 0.05), and less time lying in lateral recumbency (P < 0.05). They also spent more time at the feeder in wk 1 (P < 0.05). At the start of the trial, there were no differences in behavioral responses to handling. However, over each of the next 4 wk, fewer RAC pigs exited the home pen voluntarily, they took longer to remove from the home pen, longer to handle into the weighing scale and needed more pats, slaps, and pushes from the handler to enter the scales. At the end of wk 4, RAC pigs had higher heart rates in the presence of an unfamiliar human (P < 0.05) and during transport (P < 0.05), but not during loading and unloading. Also at the end of wk 4, RAC pigs had higher circulating catecholamine concentrations (P < 0.05) than control pigs. Circulating cortisol concentrations and cortisol responses to transport did not differ between treatments. The results show that ractopamine affected behavior, heart rate, and catecholamine profile of finishing pigs and made them more difficult to handle and potentially more susceptible to handling and transport stress.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12643485     DOI: 10.2527/2003.812416x

Source DB:  PubMed          Journal:  J Anim Sci        ISSN: 0021-8812            Impact factor:   3.159


  6 in total

1.  Urinary Excretion of the β-Adrenergic Feed Additives Ractopamine and Zilpaterol in Breast and Lung Cancer Patients.

Authors:  Ting-Yuan David Cheng; Weilin L Shelver; Chi-Chen Hong; Susan E McCann; Warren Davis; Yali Zhang; Christine B Ambrosone; David J Smith
Journal:  J Agric Food Chem       Date:  2016-09-27       Impact factor: 5.279

2.  Ractopamine, a livestock feed additive, is a full agonist at trace amine-associated receptor 1.

Authors:  Xuehong Liu; David K Grandy; Aaron Janowsky
Journal:  J Pharmacol Exp Ther       Date:  2014-05-05       Impact factor: 4.030

Review 3.  The Impacts of Climate Change Mitigation Strategies on Animal Welfare.

Authors:  Sara Shields; Geoffrey Orme-Evans
Journal:  Animals (Basel)       Date:  2015-05-21       Impact factor: 2.752

4.  Increased mortality in groups of cattle administered the β-adrenergic agonists ractopamine hydrochloride and zilpaterol hydrochloride.

Authors:  Guy H Loneragan; Daniel U Thomson; H Morgan Scott
Journal:  PLoS One       Date:  2014-03-12       Impact factor: 3.240

Review 5.  COVID-19 Effects on Livestock Production: A One Welfare Issue.

Authors:  Jeremy N Marchant-Forde; Laura A Boyle
Journal:  Front Vet Sci       Date:  2020-09-30

6.  Beta-agonist drugs modulate the proliferation and differentiation of skeletal muscle cells in vitro.

Authors:  Boimpoundi Eunice Flavie Ouali; Hao-Ven Wang
Journal:  Biochem Biophys Rep       Date:  2021-05-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.